None listed
Conditions
Brief summary
This is a prospective safety and feasibility study of a new device designed to deliver a low electrical pulse to the intestine from inside the body. Candidates for this study will be participants with Type 2 diabetes. This study intends to assess and prove that the device is safe for use for the delivery of energy within the intestine and may be an effective treatment. Participants will be followed up by the study team for up to 1-year post-procedure. This is a powered study, so there is no formal hypothesis. This research will determine whether use of this new system is safe and feasible
Interventions
This is a prospective, single-arm, interventional study evaluating the safety of a new device designed for the delivery of a low energy pulse to part of the intestine from inside the body. The new device is a gastroscope designed for endoscopic procedures within the gastrointestinal (GI) tract. Structurally and functionally, it resembles conventional gastroscopes used for diagnostic and therapeutic interventions. The device will be inserted through the mouth and the physician will guide the catheter to the location in the duodenum where the treatment will be applied. Upon positioning, energy will be delivered through the study device to the target area specified by the physician. The energy pulse will come from a generator and be delivered by a tool from inside the body that is similar in size to other commonly used tools. The energy provided is a non-thermal that will be delivered through the study device within the duodenum. Up to 9 locations in the duodenum may be treated under the investigator's discretion at a specific dosage. The duration of energy delivery is approximately 1 minute at each site. The procedure will last approximately 30 minutes. The treatment will be provided during the study procedure. There will be no additional treatments administered using the study device after the study procedure is completed. The study procedure will be performed by a highly trained gastroenterologist in an endoscopy suite. The gastroenterologist will be trained on the use of the device prior to the start of procedures. No study specific training is needed for any follow-up assessments. Adherence to the intervention will be assessed through follow-up visits performed by the study team as well as a review of medical records.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Current diagnosis of type 2 disease diagnosed within 10 years of the planned procedure 2. BMI is between 22 and 40 kg/m2 3. Able to comply with study requirements and understand and sign the Informed Consent Form
Exclusion criteria
- American Society of Anesthesia Classification of 4 or higher - Previous gastrointestinal surgery that altered gastrointestinal anatomy including but not limited to Roux-en-Y gastric bypass, sleeve gastrectomy, small bowel surgery/anastomosis and/or altered stomach-duodenum anatomy. - Contraindicated for general anesthetic agents. - Women of child-bearing potential who is pregnant, breastfeeding, lactating, or will not agree to use contraception throughout the duration of study. - Participating in another clinical investigation with an investigational drug or device within three (3) months of enrolment or planned participation at any time during this clinical investigation.